In their fiscal year 2021 reports, the US House and Senate Appropriations Committees
requested that the National Institutes of Health (NIH) evaluate current research related to …

Trauma has substantial effects on human health and is recognised as a potential barrier to
seeking or receiving cancer care. The evidence that exists regarding the effect of trauma on …

Objective Prostate cancer is the most common malignancy among men and following a
positive prostate‐specific antigen (PSA) screening test, patients may undergo more …

Introduction Cervical cancer is the fourth most common cancer worldwide and accounted for
approximately 570,000 new cancer cases and 311,000 cancer deaths in 2018. Despite …

Self-sampling for primary HPV detection for cervical cancer screening is now FDA-approved.
Many persons interested in cervical cancer screening are eager to opt out of the invasive …

Timely follow-up care after an abnormal cervical cancer screening test result is critical to the
prevention and early diagnosis of cervical cancer. The current inadequate and inequitable …

Section 2713 of the Patient Protection and Affordable Care Act (ACA) includes provisions
requiring that all ACA Marketplace and non-grandfathered private health plans eliminate …

Multi-cancer early detection (MCED) tests are blood-based tests designed to screen for
signals of multiple cancers. There is growing interest and investment in examining the …

The provision of low-value care remains a significant concern in healthcare. The negative
impacts resulting from low-value cervical cancer screenings are extensive at the population …

The preventive services provisions of the Patient Protection and Affordable Care Act (ACA)
eliminate cost-sharing for evidence-based preventive services including breast, cervical …